Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 07:17PM
|
Re: Shorts
|
3
|
Resverlogix Corp.
|
Aug 15, 2019 02:35PM
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 07:30PM
|
Re: Now published: Rationale, design, and baseline characteristics of the BETonMACE trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 04:27PM
|
Re: Top Line Mid Year
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 03:00PM
|
Re: Breakthrough Therapy Question
|
3
|
Resverlogix Corp.
|
Jan 06, 2020 04:00PM
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
3
|
Resverlogix Corp.
|
Jun 12, 2020 12:23AM
|
Re: Kidney data rocks!
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 10:21PM
|
Re: Comments re AHA presentation
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 10:38PM
|
Re: Comments re AHA presentation
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 11:04PM
|
Re: balancing success and failure
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 12:13AM
|
Re: balancing success and failure
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 12:34AM
|
Re: archived presentation is up. still no audio
|
3
|
Resverlogix Corp.
|
Nov 18, 2019 02:12PM
|
Re: Apabetalone and Alkaline Phosphatase
|
3
|
Resverlogix Corp.
|
Oct 12, 2019 11:36AM
|
Re: What we know and what we don't.....
|
3
|
Resverlogix Corp.
|
May 16, 2019 11:06PM
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 12:29PM
|
Re: Warrants conversion!
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 11:01AM
|
Re: H1 2020 Potential Events
|
3
|
Resverlogix Corp.
|
Mar 01, 2020 10:11PM
|
Re: Warrant incentive program....
|
3
|
Resverlogix Corp.
|
Feb 05, 2020 05:18PM
|
Re: Where is the bottom?
|
3
|
Resverlogix Corp.
|
Dec 12, 2019 11:50AM
|